Can amlodipine cause bradycardia
Pro Research Analysisby 
Searched over 200M research papers
Can Amlodipine Cause Bradycardia?
Introduction to Amlodipine and Bradycardia
Amlodipine is a widely used calcium channel blocker primarily prescribed for the treatment of hypertension and angina. While it is generally considered to have minimal effects on cardiac tissue due to its vasoselective properties, there have been reports of amlodipine causing bradycardia, a condition characterized by an abnormally slow heart rate.
Incidence and Case Reports of Amlodipine-Induced Bradycardia
Symptomatic Bradycardia in Healthy Individuals
Although the incidence of amlodipine-induced bradycardia is relatively low (0.89% of cases), it is a recognized side effect. For instance, a case study reported a healthy 71-year-old male developing symptomatic bradycardia while on amlodipine. His heart rate returned to normal levels within 24 hours of discontinuing the drug, highlighting the importance of recognizing this potential side effect to avoid unnecessary healthcare costs and adverse patient outcomes.
Severe Bradycardia in Overdose Situations
In cases of overdose, the risk of bradycardia increases significantly. A 66-year-old male who ingested a large quantity of amlodipine and atenolol developed severe bradycardia, hypotension, and acute kidney injury, eventually leading to cardiac arrest. Aggressive management, including the use of inotropes and calcium gluconate, was required to stabilize the patient. Another report described a 45-year-old man who experienced sinus bradycardia and hypotension following an accidental overdose of amlodipine, further emphasizing the drug's potential to cause severe bradycardia in overdose scenarios.
BRASH Syndrome and Amlodipine
Understanding BRASH Syndrome
BRASH syndrome, which stands for bradycardia, renal failure, atrioventricular nodal blockade, shock, and hyperkalemia, is a clinical entity that can be triggered by amlodipine, especially when used in combination with other AV nodal blocking agents. This syndrome represents a synergistic combination of hyperkalemia and AV nodal blockade, leading to a vicious cycle of worsening symptoms .
Case Studies of BRASH Syndrome
Several case reports have documented the occurrence of BRASH syndrome in patients taking amlodipine. For example, an 89-year-old female presented with BRASH syndrome and was successfully treated with conservative measures, avoiding invasive procedures like dialysis or pacing. Another case involved a 60-year-old woman who developed BRASH syndrome while on amlodipine and atenolol, requiring a combination of antikalaemic therapy and isoproterenol to stabilize her heart rate.
Mechanisms and Clinical Implications
Mechanisms of Bradycardia Induction
The exact mechanism by which amlodipine induces bradycardia is not fully understood. However, it is believed that in cases of acute intoxication, the drug may lose its selective action on the vascular territory and begin to depress the cardiac electrical conduction system, leading to various bradyarrhythmias.
Clinical Implications
Recognizing amlodipine-induced bradycardia is crucial for timely intervention. Discontinuation of the drug often leads to a complete resolution of symptoms, as seen in multiple case reports . Failure to identify this side effect can result in unnecessary diagnostic procedures and treatments, increasing healthcare costs and potentially worsening patient outcomes.
Conclusion
While amlodipine is generally safe and effective for treating hypertension and angina, it can cause bradycardia in certain situations, particularly in cases of overdose or when used in combination with other AV nodal blocking agents. Healthcare providers should be aware of this potential side effect and consider discontinuing the drug if bradycardia occurs, as this often leads to a rapid resolution of symptoms. Recognizing and managing amlodipine-induced bradycardia promptly can prevent serious complications and improve patient outcomes.
Sources and full results
Most relevant research papers on this topic